Literature DB >> 31385429

Histogram analysis of diffusion kurtosis imaging based on whole-volume images of breast lesions.

Ting Li1, Yuan Hong2, Dexing Kong2, Kangan Li3.   

Abstract

BACKGROUND: Breast diffusion kurtosis imaging (DKI) is a novel MRI technique to assess breast cancer but the effectivity still remains to be improved.
PURPOSE: To investigate the performance of whole-volume histogram parameters derived from a DKI model for differentiating benign and malignant breast lesions. STUDY TYPE: Retrospective. POPULATION: In all, 120 patients with breast lesions (62 malignant, 58 benign). SEQUENCE: DKI sequence with seven b-values (0, 500, 1000, 1500, 2000, 2500, and 3000 s/mm2 ) and DWI sequence with two b-values (0 and 1000 s/mm2 ) on 3.0T MRI. ASSESSMENT: Histogram parameters of the DKI model (K and D) and the DWI model (ADC), including the minimum, maximum, mean, percentile values (25th, 50th, 75th, and 95th), standard deviation, kurtosis and skewness, were calculated by two radiologists for the whole lesion volume. STATISTICAL TESTS: Student's t-test was used to compare malignant and benign lesions. The diagnostic performances were evaluated by receiver operating characteristic (ROC) analysis.
RESULTS: Kmax , Dmin , and ADCmin had the highest area under the curve (AUC) (0.875, 0.830, and 0.847, respectively), sensitivity (85.5%, 74.2%, and 77.4%, respectively), and accuracy (85.0%, 79.2%, and 81.7%, respectively) in their individual histogram parameter groups, and Kmax was found to outperform Dmin and ADCmin . ADC histogram parameters (from ADCmin to ADCsd ) were significantly lower than D histogram parameters in all groups. DATA
CONCLUSION: Kmax , Dmin , and ADCmin were found to be better metrics than the corresponding average values for differentiating benign from malignant tumors. Histogram parameters derived from the DKI model provided more information and had better diagnostic performance than ADC parameters derived from the DWI model. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2020;51:627-634.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  breast; diffusion; magnetic resonance imaging; neoplasms

Mesh:

Year:  2019        PMID: 31385429     DOI: 10.1002/jmri.26884

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  Diffusion-Weighted Imaging of Different Breast Cancer Molecular Subtypes: A Systematic Review and Meta-Analysis.

Authors:  Hans-Jonas Meyer; Andreas Wienke; Alexey Surov
Journal:  Breast Care (Basel)       Date:  2021-02-23       Impact factor: 2.860

2.  Noninvasive assessment of renal function and fibrosis in CKD patients using histogram analysis based on diffusion kurtosis imaging.

Authors:  Guanjie Yuan; Weinuo Qu; Shichao Li; Ping Liang; Kangwen He; Anqin Li; Jiali Li; Daoyu Hu; Chuou Xu; Zhen Li
Journal:  Jpn J Radiol       Date:  2022-10-18       Impact factor: 2.701

3.  Predicting the effects of radiotherapy based on diffusion kurtosis imaging in a xenograft mouse model of esophageal carcinoma.

Authors:  An-Du Zhang; Xiao-Hua Su; Yan-Fei Wang; Gao-Feng Shi; Chun Han; Nan Zhang
Journal:  Exp Ther Med       Date:  2021-02-05       Impact factor: 2.447

Review 4.  Diagnostic Performance of Diffusion Kurtosis Imaging for Benign and Malignant Breast Lesions: A Systematic Review and Meta-Analysis.

Authors:  Hongyu Gu; Wenjing Cui; Song Luo; Xiaoyi Deng
Journal:  Appl Bionics Biomech       Date:  2022-06-09       Impact factor: 1.664

Review 5.  Diffusion Breast MRI: Current Standard and Emerging Techniques.

Authors:  Ashley M Mendez; Lauren K Fang; Claire H Meriwether; Summer J Batasin; Stéphane Loubrie; Ana E Rodríguez-Soto; Rebecca A Rakow-Penner
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

6.  The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis.

Authors:  Zhipeng Li; Xinming Li; Chuan Peng; Wei Dai; Haitao Huang; Xie Li; Chuanmiao Xie; Jianye Liang
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.